Logo
Apparel & Fashion

Description

Lumefantrine represents a cornerstone in global malaria treatment, serving as a vital active pharmaceutical ingredient in combination therapies worldwide. Our company brings five decades of expertise in supplying high-quality Lumefantrine to pharmaceutical manufacturers, holding an FDA-approved bulk drug license and ensuring every batch meets stringent international quality standards including IP, BP, EP, and USP specifications. The ready stock availability ensures uninterrupted supply chains for manufacturers, while our injectable grade option provides additional formulation flexibility for critical care medications requiring immediate therapeutic intervention.

The pharmaceutical industry relies on our Lumefantrine for producing WHO-recommended artemisinin-based combination therapies that form the backbone of malaria treatment protocols. These medications are essential for national malaria control programs, international health organizations, and manufacturers serving endemic regions...
Lumefantrine represents a cornerstone in global malaria treatment, serving as a vital active pharmaceutical ingredient in combination therapies worldwide. Our company brings five decades of expertise in supplying high-quality Lumefantrine to pharmaceutical manufacturers, holding an FDA-approved bulk drug license and ensuring every batch meets stringent international quality standards including IP, BP, EP, and USP specifications. The ready stock availability ensures uninterrupted supply chains for manufacturers, while our injectable grade option provides additional formulation flexibility for critical care medications requiring immediate therapeutic intervention.

The pharmaceutical industry relies on our Lumefantrine for producing WHO-recommended artemisinin-based combination therapies that form the backbone of malaria treatment protocols. These medications are essential for national malaria control programs, international health organizations, and manufacturers serving endemic regions where reliable treatment access saves lives. Hospital networks and healthcare providers depend on consistent quality Lumefantrine to ensure treatment efficacy across diverse patient populations, while the product's compliance with multiple pharmacopeial standards makes it suitable for global distribution meeting various international regulatory requirements.

Businesses choosing our Lumefantrine benefit from unparalleled reliability backed by 50 years of industry experience and manufacturing excellence. The ready stock availability eliminates production delays and ensures treatment continuity, while multiple pharmacopeial grade options provide formulation versatility according to specific market requirements. Our FDA-approved manufacturing processes ensure batch-to-batch consistency and therapeutic effectiveness, reducing quality control burdens for clients and building trust through demonstrated commitment to product excellence and customer satisfaction in every supply partnership.

Key Features:
- Complies with IP, BP, EP, and USP pharmacopeial standards
- Available in injectable grade for versatile formulations
- FDA-approved bulk drug manufacturing license
- Ready stock availability for immediate shipment
- Consistent purity levels exceeding 99.5%

Benefits:
- Ensures global regulatory compliance for international markets
- Provides formulation flexibility for various drug delivery systems
- Guarantees manufacturing quality through FDA-approved processes
- Eliminates supply chain disruptions with immediate availability
- Delivers reliable therapeutic efficacy through consistent purity

Specifications

Additional Information
Country of OriginIndia

Application

Lumefantrine API serves as a critical component in artemisinin-based combination therapies, the WHO-recommended first-line treatment for uncomplicated Plasmodium falciparum malaria. Its mechanism involves heme-mediated decomposition within malaria parasites, effectively clearing blood-stage infections while demonstrating high efficacy and safety profiles in clinical applications across diverse patient populations. Our Lumefantrine meets multiple pharmacopeial standards including IP, BP, EP, and USP specifications, ensuring global regulatory compliance for pharmaceutical manufacturers. The injectable grade formulation enables versatile drug delivery systems while maintaining consistent potency and purity levels, making it suitable for various formulations including tablets, capsules, and critical care injectables for hospital and clinical use. - Manufacturing fixed-dose combination antimalarial tablets for global health programs - Producing pediatric formulations specifically designed for children in malaria-endemic regions - Developing emergency injectable formulations for severe and complicated malaria cases - Creating combination therapies with artemisinin derivatives for enhanced treatment efficacy - Supplying pharmaceutical companies for reliable generic antimalarial drug production

Trade Details

Available StockIn Stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

A. S. Joshi & Company, Maharashtra
TruBasic
IndiaMaharashtra, India
Distributor / Wholesaler•Importer / Exporter
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Trusted Lumefantrine API Supplier IP BP EP USP Injectable Grades

Trusted Lumefantrine API supplier since 1971 offers IP BP EP USP injectable grades with FDA-approved bulk drug license for reliable antimalarial pharmaceutical ingredients.

Min. Order Quantity: 1 unit

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

A. S. Joshi & Company
TruBasic
IndiaMaharashtra, India
Distributor / Wholesaler

More Products From Supplier